Intelligent Blood Sequestration System with Integrated Technologies

The inventive concept integrates a blood sequestration device with advanced technologies such as AI, IoT, blockchain, and nanomaterials to create a more powerful system for blood culture testing, enabling enhanced infection risk prediction, secure data storage, and real-time monitoring of blood sample quality.

The original patent addressed the need for a device to inhibit potentially contaminated blood from inclusion in a blood culture test sample. However, the existing device lacked the capabilities to analyze blood sample data, transmit results to healthcare providers, and ensure secure data storage. The new inventive concept solves these limitations by incorporating synergistic combinations of technologies to create a more comprehensive and efficient system.

The inventive concept comprises a blood sequestration device integrated with a machine learning module, a communication module, an IoT-based healthcare network, a blockchain-based data storage system, an AI-powered analysis module, and a reporting module. The machine learning module analyzes blood sample data to predict infection risks, which are transmitted to healthcare providers through the communication module. The IoT-based healthcare network enables seamless data transmission and reception. The blockchain-based data storage system ensures secure and tamper-proof storage of blood sample data and associated metadata. The AI-powered analysis module interprets test results, and the reporting module generates a comprehensive report for healthcare providers. Additionally, the device features a nanomaterial-based coating for enhanced biocompatibility and reduced risk of infection, which is integrated with a sensor module for real-time monitoring of blood sample quality.

The new claims introduce novel and non-obvious combinations of technologies, including the integration of AI, IoT, blockchain, and nanomaterials with a blood sequestration device. These synergistic combinations enable enhanced functionality, security, and efficiency in blood culture testing, distinguishing the inventive concept from the original patent.

Alternative embodiments of the inventive concept could include integrating the blood sequestration device with other advanced technologies, such as robotics or 3D printing, to further enhance its capabilities. Variations could include adapting the device for use in different medical settings or for testing different types of biological samples.

The inventive concept has significant commercial potential in the healthcare industry, particularly in the fields of infectious disease diagnosis and treatment. The system's ability to predict infection risks, ensure secure data storage, and provide real-time monitoring of blood sample quality could revolutionize the way blood culture testing is performed, making it a valuable solution for hospitals, clinics, and research institutions.